fbpx An Australian medical cannabis company just sold its first pot pills | Marijuana Business News | Cannabis Industry & Legalization | 420 Intel

An Australian medical cannabis company just sold its first pot pills

Australian medical cannabis company MMJ PhytoTech Limited has just sold its first marijuana pills. The bad news: They are only available in Europe.

The capsules were sold in August via a Swiss-based subsidiary, Satipharm. 10 milligrams of the medication will set you back 89 euros (A$139.95).

The pills are registered as a dietary supplement in Germany. Their active ingredient, Cannabidiol (CBD), is made from a special medical cannabis strain and they do not contain tetrahydrocannabinol (THC), the chemical that causes most of marijuana's psychological effects when smoked.

Research has shown that CBD can help patients suffering from cancer, anxiety and epilepsy, the company said in a statement.

The pills are free of herbicides and pesticides, according to the company's website. The operation has what it calls a "Farm to Pharma" approach to medical cannabis, producing capsules that are traceable from seedlings to pills.

"August was a month of 'firsts'...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.